HepaCAM inhibits cell proliferation and invasion in prostate cancer by suppressing nuclear translocation of the androgen receptor via its cytoplasmic domain-Reference-Cited by-同舟云学术

HepaCAM inhibits cell proliferation and invasion in prostate cancer by suppressing nuclear translocation of the androgen receptor via its cytoplasmic domain

Published:2019-01-10 Issue: Volume: Page:
ISSN:1791-2997
Container-title:Molecular Medicine Reports
language:
Short-container-title:Mol Med Report

Author:

Deng Qingfu¹,Luo Li²,Quan Zhen¹,Liu Nanjing²,Du Zhongbo¹,Sun Wei¹,Luo Chunli²,Wu Xiaohou¹

Affiliation:

1. Department of Urology, First Affiliated Hospital of Chongqing Medical University, Chongqing 400042, P.R. China

2. Key Laboratory of Diagnostics Medicine Designated by The Ministry of Education, Chongqing Medical University, Chongqing 400042, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,Genetics,Molecular Biology,Molecular Medicine,Biochemistry

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of subclusters and prognostic genes based on GLS-associated molecular signature in ulcerative colitis;Scientific Reports;2024-06-07

2. Glial Cell Adhesion Molecule (GlialCAM) Determines Proliferative versus Invasive Cell States in Glioblastoma;The Journal of Neuroscience;2023-09-18

3. [Corrigendum] HepaCAM inhibits cell proliferation and invasion in prostate cancer by suppressing nuclear translocation of the androgen receptor via its cytoplasmic domain;Molecular Medicine Reports;2022-05-23

4. HepaCAM‑PIK3CA axis regulates the reprogramming of glutamine metabolism to inhibit prostate cancer cell proliferation;International Journal of Oncology;2022-02-22